Mineralocorticoid Receptor Antagonism Improved the Metabolic Function in a Mouse Model With Chronic Kidney Disease and Obesity

被引:0
|
作者
Ramirez, Roberto Palacios
Bonnard, Benjamin
Jaisser, Frederic
机构
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
P178
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Mineralocorticoid receptor antagonists for cardioprotection in chronic kidney disease: a step into the future
    Maria-Eleni Alexandrou
    Marieta P. Theodorakopoulou
    Mehmet Kanbay
    Pantelis A. Sarafidis
    [J]. Journal of Human Hypertension, 2022, 36 : 695 - 704
  • [32] Mineralocorticoid receptor antagonists for cardioprotection in chronic kidney disease: a step into the future
    Alexandrou, Maria-Eleni
    Theodorakopoulou, Marieta P.
    Kanbay, Mehmet
    Sarafidis, Pantelis A.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2022, 36 (08) : 695 - 704
  • [33] Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease
    Rosenberg, Mai
    Bagrov, Alexei Y.
    [J]. FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [34] Finerenone: a new mineralocorticoid receptor antagonist to beat chronic kidney disease
    Raj, Rajesh
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2022, 31 (03): : 265 - 271
  • [35] Mineralocorticoid antagonists in chronic kidney disease
    Al Dhaybi, Omar
    Bakris, George
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2017, 26 (01): : 50 - 55
  • [36] Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure
    Ferreira, Joao Pedro
    Santos, Mario
    Almeida, Sofia
    Marques, Irene
    Bettencourt, Paulo
    Carvalho, Henrique
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (01) : 67 - 72
  • [37] Effect of iron restriction on renal damage and mineralocorticoid receptor signaling in a rat model of chronic kidney disease
    Naito, Yoshiro
    Fujii, Aya
    Sawada, Hisashi
    Hirotani, Shinichi
    Iwasaku, Toshihiro
    Eguchi, Akiyo
    Ohyanagi, Mitsumasa
    Tsujino, Takeshi
    Masuyama, Tohru
    [J]. JOURNAL OF HYPERTENSION, 2012, 30 (11) : 2192 - 2201
  • [38] Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease
    Zachariah, Teena
    Radhakrishnan, Jai
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
  • [39] Mineralocorticoid Receptor Antagonism and Aldosterone Synthesis Inhibition Do Not Improve Glomerulosclerosis and Renal Interstitial Fibrosis in a Model of Chronic Kidney Allograft Injury
    Lahmer, Tobias
    Hermans, Rob
    Schmaderer, Christoph
    Chang, Jianxing
    Stock, Konrad
    Lutz, Jens
    Heemann, Uwe
    Baumann, Marcus
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (06): : 561 - 567
  • [40] Selective endothelin A receptor antagonism in patients with proteinuric chronic kidney disease
    Provenzano, Michele
    Andreucci, Michele
    Garofalo, Carlo
    Minutolo, Roberto
    Serra, Raffaele
    De Nicola, Luca
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2021, 30 (03) : 253 - 262